Westfield Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-69,100
Closed -$525K 329
2013
Q4
$525K Buy
69,100
+30,100
+77% +$229K ﹤0.01% 295
2013
Q3
$284K Buy
+39,000
New +$284K ﹤0.01% 332